Impact Ureteral Sheath Design During Ureteroscopy
The Impact of Ureteral Access Sheath Design on Ease of Placement and Ureteral Wall Injury During Flexible Ureteroscopy
1 other identifier
interventional
95
0 countries
N/A
Brief Summary
The purpose of this study is to assess whether one of two ureteral access sheaths is safer for patients undergoing ureteroscopy. Both sheaths are FDA approved devices and commercially available. The investigators will compare the ability of sheaths to access the kidney through the ureter and will compare damage done to the ureter after completion of the procedure. Access sheaths are standard of care for this procedure; this study seeks to optimize outcomes for patients. Patients undergoing ureteroscopy who do not have ureteral stents in place and who have not had an ipsilateral procedure within 90 days will be recruited and consented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 13, 2017
CompletedFirst Posted
Study publicly available on registry
November 21, 2017
CompletedResults Posted
Study results publicly available
January 23, 2018
CompletedJanuary 23, 2018
December 1, 2017
2 years
November 13, 2017
November 29, 2017
December 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Successful Sheath Placement
The surgeon documents whether there was Successful placement of sheath (yes or no)
One time point - at the beginning of the procedure
Secondary Outcomes (2)
Number of Participants With Injury to the Ureter
One time point - at the completion of the procedure
Ease of Sheath Placement
One time point - at the completion of the procedure
Study Arms (2)
Cook Flexor
ACTIVE COMPARATORureteral access sheath
Boston Scientific Navigator HD
ACTIVE COMPARATORureteral access sheath
Interventions
Eligibility Criteria
You may qualify if:
- Patients planned for ureteroscopy
- Current CT scan within 90-days before the operation
- Able to give informed consent
- Ages 18 years and older
You may not qualify if:
- Inability to give informed consent
- Age less than 18 years
- Pregnant
- Stones in the ureter
- Having previous ipsilateral ureteral or renal surgery within 90 days
- Having stents placed in ipsilateral ureter within 90 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (12)
Kourambas J, Byrne RR, Preminger GM. Does a ureteral access sheath facilitate ureteroscopy? J Urol. 2001 Mar;165(3):789-93.
PMID: 11176469BACKGROUNDRehman J, Monga M, Landman J, Lee DI, Felfela T, Conradie MC, Srinivas R, Sundaram CP, Clayman RV. Characterization of intrapelvic pressure during ureteropyeloscopy with ureteral access sheaths. Urology. 2003 Apr;61(4):713-8. doi: 10.1016/s0090-4295(02)02440-8.
PMID: 12670551BACKGROUNDPietrow PK, Auge BK, Delvecchio FC, Silverstein AD, Weizer AZ, Albala DM, Preminger GM. Techniques to maximize flexible ureteroscope longevity. Urology. 2002 Nov;60(5):784-8. doi: 10.1016/s0090-4295(02)01948-9.
PMID: 12429296BACKGROUNDAuge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004 Feb;18(1):33-6. doi: 10.1089/089277904322836631.
PMID: 15006050BACKGROUNDLallas CD, Auge BK, Raj GV, Santa-Cruz R, Madden JF, Preminger GM. Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol. 2002 Oct;16(8):583-90. doi: 10.1089/089277902320913288.
PMID: 12470467BACKGROUNDTraxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. J Urol. 2013 Feb;189(2):580-4. doi: 10.1016/j.juro.2012.08.197. Epub 2012 Oct 8.
PMID: 22982421BACKGROUNDSchoenthaler M, Wilhelm K, Kuehhas FE, Farin E, Bach C, Buchholz N, Miernik A. Postureteroscopic lesion scale: a new management modified organ injury scale--evaluation in 435 ureteroscopic patients. J Endourol. 2012 Nov;26(11):1425-30. doi: 10.1089/end.2012.0227. Epub 2012 Aug 27.
PMID: 22698147BACKGROUNDDelvecchio FC, Auge BK, Brizuela RM, Weizer AZ, Silverstein AD, Lallas CD, Pietrow PK, Albala DM, Preminger GM. Assessment of stricture formation with the ureteral access sheath. Urology. 2003 Mar;61(3):518-22; discussion 522. doi: 10.1016/s0090-4295(02)02433-0.
PMID: 12639636BACKGROUNDAyyathurai R, Kanagarajah P, Shields J, Young E, Alvarez A, Bird VG. Single-center clinical comparison of two reinforced ureteral access sheaths for retrograde ureteroscopic treatment of urinary lithiasis. Int Urol Nephrol. 2012 Apr;44(2):409-14. doi: 10.1007/s11255-011-0017-8. Epub 2011 Jun 25.
PMID: 21706214BACKGROUNDDe S, Sarkissian C, Torricelli FC, Brown R, Monga M. New ureteral access sheaths: a double standard. Urology. 2015 Apr;85(4):757-63. doi: 10.1016/j.urology.2014.07.009. Epub 2015 Feb 4.
PMID: 25661780BACKGROUNDMogilevkin Y, Sofer M, Margel D, Greenstein A, Lifshitz D. Predicting an effective ureteral access sheath insertion: a bicenter prospective study. J Endourol. 2014 Dec;28(12):1414-7. doi: 10.1089/end.2014.0215.
PMID: 25244070BACKGROUNDFuganti PE, Pires S, Branco R, Porto J. Predictive factors for intraoperative complications in semirigid ureteroscopy: analysis of 1235 ballistic ureterolithotripsies. Urology. 2008 Oct;72(4):770-4. doi: 10.1016/j.urology.2008.05.042. Epub 2008 Jul 16.
PMID: 18632141BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Manoj Monga MD
- Organization
- Cleveland Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Manoj Monga, MD
Urologist
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Videos will be analyzed by blinded urologists who will rate the extent of ureteral damage on a standardized scale of 0 to 4 according to the study published by Traxer et al. 2013. After the study, subjects will not be contacted.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Endourology and Stone Disease
Study Record Dates
First Submitted
November 13, 2017
First Posted
November 21, 2017
Study Start
June 27, 2014
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
January 23, 2018
Results First Posted
January 23, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share